Literature DB >> 18219109

Chromosomal genotype in breast cancer progression: comparison of primary and secondary manifestations.

Katrin Friedrich1, Theresa Weber, Jens Scheithauer, Wolfdietrich Meyer, Gunter Haroske, Klaus Dietmar Kunze, Gustavo Baretton.   

Abstract

The purpose of this study was to compare the chromosomal genotype between breast cancers with and without secondary manifestations and between primary tumors and their secondary manifestations. Eighty six breast cancers, twenty lymph node metastases, ten distant metastases and ten local recurrences were analyzed by comparative genomic hybridization. Tumors with local recurrences showed significant more frequent losses at 2q32 than the tumors without recurrences. Lymph node positive cases showed significant more frequent losses at 9p21 than node negative cases. Lymph node metastases exhibited significant more frequent losses at 7q11, 14q24.3-q31 and 17q22-q24 than their primary tumors. In cases with distant metastases, losses at 5q23 were more frequent than in those without, but not reaching the significance level. The distant metastases showed significant more frequent losses at 5p15, 12q24 and 17q22-q24 than the primary tumors. These results reveal strong evidence that the potential for progression is determined in the primary tumor and that different ways of the development of local recurrences, lymph node and distant metastases exist. After confirmation of the results by interphase FISH on tissue micro arrays, the detection of these specific chromosomal imbalances may contribute to a more individual prediction of prognosis in breast cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18219109      PMCID: PMC4618578          DOI: 10.1155/2008/209142

Source DB:  PubMed          Journal:  Cell Oncol        ISSN: 1570-5870            Impact factor:   6.730


  9 in total

1.  SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis.

Authors:  Sait Ozturk; Panagiotis Papageorgis; Chen Khuan Wong; Arthur W Lambert; Hamid M Abdolmaleky; Arunthathi Thiagalingam; Herbert T Cohen; Sam Thiagalingam
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-06       Impact factor: 11.205

2.  Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma.

Authors:  Nicole M A White; Daniel W Newsted; Olena Masui; Alexander D Romaschin; K W Michael Siu; George M Yousef
Journal:  Tumour Biol       Date:  2013-10-19

3.  Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis.

Authors:  Anne Bruun Krøigård; Martin Jakob Larsen; Anne-Vibeke Lænkholm; Ann S Knoop; Jeanette D Jensen; Martin Bak; Jan Mollenhauer; Torben A Kruse; Mads Thomassen
Journal:  Oncotarget       Date:  2015-03-20

4.  Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer.

Authors:  Naoko Minatani; Mina Waraya; Keishi Yamashita; Mariko Kikuchi; Hideki Ushiku; Ken Kojo; Akira Ema; Hiroshi Nishimiya; Yoshimasa Kosaka; Hiroshi Katoh; Norihiko Sengoku; Hirokazu Tanino; David Sidransky; Masahiko Watanabe
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

5.  Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth.

Authors:  Yan Dong; Baoping Cao; Meiying Zhang; Weidong Han; James G Herman; François Fuks; Yali Zhao; Mingzhou Guo
Journal:  Oncotarget       Date:  2015-09-08

6.  Integrated landscape of copy number variation and RNA expression associated with nodal metastasis in invasive ductal breast carcinoma.

Authors:  Michael Behring; Sadeep Shrestha; Upender Manne; Xiangqin Cui; Agustin Gonzalez-Reymundez; Alexander Grueneberg; Ana I Vazquez
Journal:  Oncotarget       Date:  2018-12-07

7.  Gene Expression Meta-Analysis Identifies Cytokine Pathways and 5q Aberrations Involved in Metastasis of ERBB2 Amplified and Basal Breast Cancer.

Authors:  Mads Thomassen; Qihua Tan; Mark Burton; Torben A Kruse
Journal:  Cancer Inform       Date:  2013-11-25

8.  Lack of genomic heterogeneity at high-resolution aCGH between primary breast cancers and their paired lymph node metastases.

Authors:  Marieke A Vollebergh; Christiaan Klijn; Philip C Schouten; Jelle Wesseling; Danielle Israeli; Bauke Ylstra; Lodewyk F A Wessels; Jos Jonkers; Sabine C Linn
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

9.  Array comparative genomic hybridization of 18 pancreatic ductal adenocarcinomas and their autologous metastases.

Authors:  Valentin Rausch; Andreas Krieg; Jordi Camps; Bianca Behrens; Manfred Beier; Darawalee Wangsa; Kerstin Heselmeyer-Haddad; Stephan E Baldus; Wolfram T Knoefel; Thomas Ried; Nikolas H Stoecklein
Journal:  BMC Res Notes       Date:  2017-11-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.